NEW YORK (Reuters Health) – Statins do not show the desired effect of lowering blood cholesterol levels in about half of the patients they are prescribed, according to a recent study.
Statins are a popular drug group that is widely used to lower the level of cholesterol in the blood.
The latest study involved more than 160,000 people in the UK who had high blood cholesterol level, and those levels were verified two years after starting treatment with statins.
The researchers found that about half of the patients did not respond well enough to statins, so their cholesterol levels did not drop to more than 40%.
Such patients face a higher risk of future CVD.
On the other hand, researchers argue that the problem may not be in the statins themselves, there is not enough information to explain why these patients did not respond to the treatment of statins adequately.
The results of this study confirm the importance of doctors monitoring their patients during statin treatment and to guide them to further measures if cholesterol levels are not properly reduced, such as healthy lifestyles that include diet and exercise, or increased dosage.
The study was conducted by researchers from the University of Nottingham and was recently published in the Heart Journal.
Source: British National Health Service (NHS)